User:Aquaman2014/sandbox

PROCEPT BioRobotics
PROCEPT BioRobotics is a privately held medical device company based in the Silicon Valley in Redwood Shores, California and develops minimally invasive technology to surgically treat prostate disease and is the first company to combine image guidance and robotics with water for targeted and heat-free removal of prostate tissue. Using image guidance and robotics, PROCEPT has been able to harvest The Power of Water™.

History
PROCEPT was founded in 2009 by Drs. Nikolai Aljuri and Rodney Perkins to develop a better surgical solution for the treatment of prostate glandular disease. The first product developed is the, an intelligent image-guided robotic system delivering Aquablation, a personalized waterjet tissue resection modality. Under real-time image-based ultrasonic guidance, enables surgical planning and mapping, and allows for precisely controlled resection of the prostate using a high-velocity saline stream.

On January 25, 2013, the first two patients were treated with Aquablation and the procedures were performed at Tauranga Hospital in New Zealand by Dr. Peter Gilling. Dr. Peter Gilling is known for his work in pioneering the HoLEP procedure, Holmium Laser Enucleation of the Prostate. HoLEP is another Holmium laser procedure reported to carry fewer risks compared with either TURP or open prostatectomies. On July 7, 2015, PROCEPT announced the closing of $42 million in new funding led by Novo A/S. CPMG, Inc. and existing investors also participated in the round. PROCEPT will use the proceeds from the financing for a limited commercial launch of AquaBeam in targeted international markets and to conduct the WATER study (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue), a randomized blinded controlled clinical trial. PROCEPT has received conditional approval from the FDA for an investigational device exemption trial in the United States to evaluate the safety and effectiveness of Aquablation.

Corporate Governance
PROCEPT BioRobotics’ founder and Chief Executive Officer is Nikolai Aljuri, Ph.D. with its co-founder, Dr. Rodney Perkins serving as the Chairman of the Board. Other Board members include Antal Desai, Dr. Thomas Krummel, Dr. Frederic Moll, Jack Nielsen, Eric Reuter, and Kolby Wood. Other executives include Surag Mantri, Vice President of Research & Development, Matt Salkeld, Vice President of Sales and Marketing, and Steve Fermi, Vice President of Clinical Affairs.